Researchers with the American Gastroenterological Association (AGA) release a comprehensive set of guidelines on the use of biomarkers for monitoring and managing Crohn disease in patients.
After clinical trials to assess the safety, efficacy, and maintenance use, the FDA has approved the first oral treatment for moderately to severely active Crohn disease.
Perianal Crohn disease (CD) is persistent, and treating patients is challenging. Authors of a new study sought to assess the effectiveness of vedolizumab in perianal CD and the predictors of success in a...
Stephen Hanauer, MD, from Northwestern Medicine, discussed key windows of opportunity for effective management of Crohn disease during his presentation at the Advances in Inflammatory Bowel Diseases...
Researchers performed small RNA sequencing of colon tissue from more than 100 individuals to better understand cellular mechanisms that create heterogeneity in CD.
In a plenary session at ACG 2018, Dr Adeeti Chiplunker from Washington University discussed her research on the effect of magnetic resonance enterography on the management of small bowel Crohn disease. ...
Consultant360 recently spoke with David Suskind, MD, who presented at Advances in Inflammatory Bowel Diseases 2017, about the importance of diet as a first-line therapy for pediatric patients with Crohn...
Crohn disease will likely recur postoperatively without the use of prophylaxis. However, little evidence for optimal treatment options currently exists.
It is not currently known whether the early use of azathioprine treatment can alter the natural history of Crohn disease. In a recent study, researchers evaluated the effects of the treatment in patients...
Little information exists on the association between fertility rates and medication safety in men with inflammatory bowel disease. Researchers sought to investigate this relationship further in a recent...
